Fiche publication
Date publication
septembre 2025
Journal
Alimentary pharmacology & therapeutics
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent
Tous les auteurs :
Massironi S, Zilli A, Furfaro F, Allocca M, Peyrin-Biroulet L, Jairath V, Danese S
Lien Pubmed
Résumé
Inflammatory bowel disease (IBD) is a chronic, resource-intensive condition requiring repeated diagnostic assessments. Healthcare contributes ~5% of global greenhouse gas emissions, and key diagnostic tools in IBD-gastrointestinal (GI) endoscopy, computed tomography (CT) and magnetic resonance imaging (MRI)-are associated with substantial environmental impacts. The environmental burden of these diagnostic pathways, however, remains underappreciated.
Référence
Aliment Pharmacol Ther. 2025 09 23;:
